Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03568019 · ClinicalTrials.gov registry record
PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
A clinical trial of Cachexia; Cancer, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT03568019 is a study of Cachexia; Cancer that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03568019, a study of Cachexia; Cancer, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
PET has an established role in the initial staging of patients with newly diagnosed lung and gastrointestinal tumors.PET avidity is described with both maximum and mean standardized uptake values.Malignant cells have increased activity on PET, defined as the standardized uptake value (SUV), with increased uptake of FDG in tumor due to elevated levels of GLUT receptors, elevated intracellular levels of hexokinase and increased rates of glycolysis. However, there is a subset of patients with lung and gastrointestinal tumors that are not PET avid.These patients may present with clinically and systemically aggressive disease with a declining performance status and/or weight loss.
Conditions Studied
Interventions
- OTHER Retrospective study
Study Locations (1)
Texas
- UT Southwestern Medical Centre - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03568019
The ClinicalTrials.gov registry entry for NCT03568019 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cachexia; Cancer appearing as the primary indexed condition, and to 1 intervention - of which Retrospective study is the first listed.
NCT03568019 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03568019 about?
NCT03568019 is a clinical study titled "PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors". PET has an established role in the initial staging of patients with newly diagnosed lung and gastrointestinal tumors.PET avidity is described with both maximum and mean standardized uptake values.Malignant cells have increased activity on PET, defined as the standardized uptake value (SUV), with inc...
What is the current status of trial NCT03568019?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2013-11-26. Estimated completion is 2027-12-31.
What conditions does trial NCT03568019 study?
This clinical trial studies the following conditions: Cachexia; Cancer.
What interventions are being tested in trial NCT03568019?
The interventions under investigation include: Retrospective study (OTHER).
Who is sponsoring clinical trial NCT03568019?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03568019 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cachexia; Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.